Table 1.

Associations of SDF1-3′A With NHL and Other AIDS Indicator Conditions in HIV-1–Infected Patients

No. of SDF1 +/+ No. of SDF1 +/3′A Odds Ratio 95% CI No. of SDF1 3′A/3′A Odds Ratio95% CI
NHL  24  22  2.5  (1.3-4.8)  6  5.1 (1.6-14)  
 By subtype  
  Burkitt’s and Burkitt-like 1  4  11  (1.1-500)  1  20  (0.3-1600) 
  Primary brain  4  6  4.1  (1.0-20)  2  10 (0.9-70)  
  Large-cell, immunoblastic, other types  19 12  1.7  (0.7-3.8)  3  3.2  (0.6-12)  
Kaposi’s sarcoma* 13  9  1.4  (0.5-3.9)  1  1.2  (0.0-13) 
Opportunistic infection 194  76  1.0  (0.7-1.4) 10  0.8  (0.3-1.9)  
No AIDS indicator clinical conditions 301  105  0.8  (0.5-1.1)  17  0.9 (0.4-2.1) 
No. of SDF1 +/+ No. of SDF1 +/3′A Odds Ratio 95% CI No. of SDF1 3′A/3′A Odds Ratio95% CI
NHL  24  22  2.5  (1.3-4.8)  6  5.1 (1.6-14)  
 By subtype  
  Burkitt’s and Burkitt-like 1  4  11  (1.1-500)  1  20  (0.3-1600) 
  Primary brain  4  6  4.1  (1.0-20)  2  10 (0.9-70)  
  Large-cell, immunoblastic, other types  19 12  1.7  (0.7-3.8)  3  3.2  (0.6-12)  
Kaposi’s sarcoma* 13  9  1.4  (0.5-3.9)  1  1.2  (0.0-13) 
Opportunistic infection 194  76  1.0  (0.7-1.4) 10  0.8  (0.3-1.9)  
No AIDS indicator clinical conditions 301  105  0.8  (0.5-1.1)  17  0.9 (0.4-2.1) 
*

In male homosexuals only.

Includes all AIDS-defining clinical conditions except for NHL and Kaposi’s sarcoma.

Close Modal

or Create an Account

Close Modal
Close Modal